VolitionRx Limited Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate
VolitionRx Limited (VNRX) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate of 72.34% for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate · last filed 2023-11-14
- 2023-09-30: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 9 month 72.34%.
- 2023-06-30: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 6 month 71.96%.
- 2023-06-01: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 0 month 71.56%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 0 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 6 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 9 month |
|---|---|---|---|
| 2023-09-30 | 72.34% 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 71.96% 10-Q · filed 2023-08-14 | ||
| 2023-06-01 | 71.56% 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |